Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Diabetes, Cardiovascular Risks, and Lipoproteins
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
1,085
Works
IDs:OpenAlex
How has Diabetes, Cardiovascular Risks, and Lipoproteins's publication output changed over time?
ScholarIQpublication output · 2005–2023
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2023.
1
1
1
1
1
1
1
3
1
1
2005200820102012201320152016201720192023
What are the most-cited papers on Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQmost cited works
Diagnosis and Management of the Metabolic Syndrome
Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, John A. Spertus, Fernando Costa
Circulation. 200511,851 CitationsOPEN ACCESS
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A. Motala, Katherine Ogurtsova, Jonathan E. Shaw, Dominic Bright, Rhys Williams
Diabetes Research and Clinical Practice. 201910,642 Citations
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The Action to Control Cardiovascular Risk in Diabetes Study Group
New England Journal of Medicine. 20087,920 CitationsOPEN ACCESS
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Katherine Ogurtsova, João Diogo da Rocha Fernandes, Yadi Huang, Ute Linnenkamp, Leonor Guariguata, N.H. Cho, David Cavan, Jonathan E. Shaw, Lydia Makaroff
Diabetes Research and Clinical Practice. 20177,076 Citations
Heart Disease and Stroke Statistics—2016 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, Donna K. Arnett, Michael J. Blaha, Mary Cushman, Sandeep R. Das, Sarah D. de Ferranti, Jean‐Pierre Després, Heather J. Fullerton, Virginia J. Howard, Mark D. Huffman, Carmen R. Isasi, Monik C. Jiménez, Suzanne E. Judd, Brett Kissela, Judith H. Lichtman, Lynda D. Lisabeth, Simin Liu, Rachel H. Mackey, David J. Magid, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Paul Muntner, Michael E. Mussolino, Khurram Nasir, Robert W. Neumar, Graham Nichol, Latha Palaniappan, Dilip K. Pandey, Mathew J. Reeves, Carlos J. Rodríguez, Wayne D. Rosamond, Paul D. Sorlie, Joel Stein, Amytis Towfighi, Tanya N. Turan, Salim S. Virani, Daniel Woo, Robert W. Yeh, Melanie B. Turner
Circulation. 20156,648 Citations
Where is Diabetes, Cardiovascular Risks, and Lipoproteins research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Diabetes, Cardiovascular Risks, and Lipoproteins is open access?
ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
20%
Bronze
40%
Closed
40%
Related on ScholarIQ
Diagnosis and Management of the Metabolic Syndrome
Paper
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Paper
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Paper
Prediction of Coronary Heart Disease Using Risk Factor Categories
Paper
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
Paper
Effects of Intensive Glucose Lowering in Type 2 Diabetes
Paper